Other OTC • Healthcare • Drug Manufacturers - General • JP • USD
Ono Pharmaceutical Co., Ltd. (OPHLY) has a consensus analyst rating of Sell, based on 2 analysts covering the stock. Of those, 0 recommend buying, 0 recommend holding, and 2 recommend selling.
No price target data available.
Be the first to know when stocks drop below their intrinsic value.
